Literature DB >> 23890799

Mitochondrial-derived N-formyl peptides: novel links between trauma, vascular collapse and sepsis.

C F Wenceslau1, C G McCarthy, S Goulopoulou, T Szasz, E G NeSmith, R C Webb.   

Abstract

Sepsis is a major cause of mortality and morbidity in trauma patients despite aggressive treatment. Traumatic injury may trigger infective or non-infective systemic inflammatory response syndrome (SIRS) and sepsis. Sepsis and SIRS are accompanied by an inability to regulate the inflammatory response but the cause of this perturbation is still unknown. The major pathophysiological characteristic of sepsis is the vascular collapse (i.e., loss of control of vascular tone); however, at the cellular level the final mediator of extreme vasodilatation has yet to be identified. After trauma, cellular injury releases endogenous damage-associated molecular patterns (DAMPs) that activate the innate immune system. Mitochondrial DAMPs express at least two molecular signatures, N-formyl peptides and mitochondrial DNA that act on formyl peptide receptors (FPRs) and Toll-like receptor 9, respectively. N-Formyl peptides are potent immunocyte activators and, once released in the circulation, they induce modulation of vascular tone by cellular mechanisms that are not completely understood. We have observed that N-formyl peptides from bacterial (FMLP) and mitochondrial (FMIT) sources induce FPR-mediated vasodilatation in resistance arteries. Accordingly, we propose that tissue and cellular trauma induces the release of N-formyl peptides from mitochondria triggering inflammation and vascular collapse via activation of FPR and contributing to the development of sepsis. The proposed hypothesis provides clinically significant information linking trauma, mitochondrial N-formyl peptides and inflammation to vascular collapse and sepsis. If our hypothesis is true, it may lead to new strategies in the management of sepsis that can help clinicians effectively manage non-infectious and infectious inflammatory responses.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23890799      PMCID: PMC9316415          DOI: 10.1016/j.mehy.2013.06.026

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   4.411


  25 in total

Review 1.  Pleiotropic roles of formyl peptide receptors.

Authors:  Y Le; J J Oppenheim; J M Wang
Journal:  Cytokine Growth Factor Rev       Date:  2001-03       Impact factor: 7.638

Review 2.  Formyl-peptide receptors revisited.

Authors:  Yingying Le; Philip M Murphy; Ji Ming Wang
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

Review 3.  Novel strategies for the treatment of sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Peter A Ward
Journal:  Nat Med       Date:  2003-05       Impact factor: 53.440

Review 4.  Epidemiology of sepsis: an update.

Authors:  D C Angus; R S Wax
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

5.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

6.  The role of endothelium and endogenous vasoactive substances in sepsis.

Authors:  G Kotsovolis; K Kallaras
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

7.  Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.

Authors:  Marie-Josèphe Rabiet; Emilie Huet; François Boulay
Journal:  Eur J Immunol       Date:  2005-08       Impact factor: 5.532

Review 8.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Indomethacin improves survival in gram-negative sepsis.

Authors:  B L Short; M Gardiner; R I Walker; S R Jones; J R Fletcher
Journal:  Adv Shock Res       Date:  1981

10.  NO contributes to abnormal vascular calcium regulation and reactivity induced by peritonitis-associated septic shock in rats.

Authors:  Shiu-Jen Chen; Shaio-Yun Li; Chih-Chin Shih; Mei-Huei Liao; Chin-Chen Wu
Journal:  Shock       Date:  2010-05       Impact factor: 3.454

View more
  19 in total

Review 1.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

Review 2.  Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors.

Authors:  Dominik Alexander Bloes; Dorothee Kretschmer; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2014-12-15       Impact factor: 60.633

3.  Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome.

Authors:  Camilla Ferreira Wenceslau; Cameron G McCarthy; Theodora Szasz; Styliani Goulopoulou; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-01-30       Impact factor: 4.733

4.  Peritoneal cavity lavage reduces the presence of mitochondrial damage associated molecular patterns in open abdomen patients.

Authors:  Patricia A Martinez-Quinones; Cameron G McCarthy; Caleb J Mentzer; Camilla F Wenceslau; Steven B Holsten; R Clinton Webb; Keith O'Malley
Journal:  J Trauma Acute Care Surg       Date:  2017-12       Impact factor: 3.313

Review 5.  Mitochondrial damage-associated molecular patterns and vascular function.

Authors:  Camilla Ferreira Wenceslau; Cameron G McCarthy; Theodora Szasz; Kathryn Spitler; Styliani Goulopoulou; R Clinton Webb
Journal:  Eur Heart J       Date:  2014-02-25       Impact factor: 29.983

6.  Lipoxin A4 mediates aortic contraction via RHOA/RHO kinase, endothelial dysfunction and reactive oxygen species.

Authors:  Camilla F Wenceslau; Cameron Grant McCarthy; Theodora Szasz; R Clinton Webb
Journal:  J Vasc Res       Date:  2015-01-21       Impact factor: 1.934

Review 7.  Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?

Authors:  Kavya Srinivasan; Ashutosh Kumar Pandey; Ashlena Livingston; Sundararajan Venkatesh
Journal:  Mol Biomed       Date:  2021-11-23

Review 8.  Mitochondria in innate immune signaling.

Authors:  Balaji Banoth; Suzanne L Cassel
Journal:  Transl Res       Date:  2018-08-07       Impact factor: 7.012

Review 9.  Role of Mitochondria-Derived Danger Signals Released After Injury in Systemic Inflammation and Sepsis.

Authors:  Kiyoshi Itagaki; Ingred Riça; Barbora Konecna; Hyo In Kim; Jinbong Park; Elzbieta Kaczmarek; Carl J Hauser
Journal:  Antioxid Redox Signal       Date:  2021-05-25       Impact factor: 7.468

10.  Mitochondrial Damage-Associated Molecular Patterns (MTDs) Are Released during Hepatic Ischemia Reperfusion and Induce Inflammatory Responses.

Authors:  Qianni Hu; Caroline Ruth Wood; Sanem Cimen; Ananda Baskaran Venkatachalam; Ian Patrick Joseph Alwayn
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.